Intended as a pilot study, the results should be interpreted as such, and further studies evaluating the association of ACE2 and TMPRSS2 levels and disease course and outcome in larger cohorts of COVID-19 patients would be needed as external validation of our findings. The gene discussed is ACE2; the disease is COVID-19.